Autres langues Biogen Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
208,9 ^USD	+3,18%		+7,47%	-19,27%

26/04	BIOGEN INC. : Guggenheim est neutre sur le titre	ZM
25/04	Biogen Inc. TOFIDence (tocilizumab), un biosimilaire de ROACTEMRA, reçoit un avis positif du CHMP	CI

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®	25/04
Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA	25/04
Health Care Down Amid Mixed Earnings -- Health Care Roundup	24/04
Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on October 21, 2020.	24/04
Biogen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Sector Update: Health Care Stocks Slipping Late Afternoon	24/04
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET	24/04
Wall St edges lower as rising yields overshadow upbeat corporate results	24/04
Aktien New York: Moderate Gewinne im Technologiebereich	24/04
Sector Update: Health Care Stocks Softer Wednesday Afternoon	24/04
Sector Update: Health Care	24/04
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET	24/04
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	24/04
Biogen Affirms Guidance After Mixed First Quarter	24/04
Nasdaq outshines Wall St peers on tech boost, earnings glee	24/04
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	24/04
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday	24/04
Borsa Usa, futures S&P, Nasdaq in rialzo su spinta settore tech	24/04
Biogen's Q1 Adjusted Earnings Rise, Revenue Falls; Reaffirms 2024 Adjusted Earnings Guidance, Shares Gain 4% Pre-Bell	24/04
Biogen : augmentation de 8% du BPA trimestriel	24/04

Aucun résultat pour cette recherche